CERO THERAPEUTICS HOLDINGS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Deferred Tax Assets, Goodwill and Intangible Assets of $361.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $361.00K.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $403.00K.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $401.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $361.00K 10-K · filed 2026-04-15 |
| 2024-12-31 | $403.00K 10-K · filed 2026-04-15 |
| 2023-12-31 | $401.00K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |